This action aims to support actions of innovation and sustainability that can empower the pharmaceutical and health products taking into account both the context of the output of the crisis resulting from the COVID 19 such as the need for a recovery in key ecological, on the basis of climate neutrality and environmental protection, all through the implementation of industrial research, technological development, innovation in processes and organization, as well as investments aimed at sustainability by improving the efficiency and environmental protection beyond the rules of the union.
Ayúdenos a mejorar. Si lo desea puede cumplimentar esta encuesta de calidad de nuestros servicios.
Thanks for your comments.